LILLY ENDOWMENT INC 4

What Happened Lilly Endowment Inc., reported as a 10% owner of Eli Lilly & Co. (LLY), disposed of a total of 15,828 shares on May 6, 2026 in open-market/private sale transactions. The filing shows two grouped dispositions: 13,620 shares at a weighted-average price of $995.23 (≈ $13,554,965) and 2,208 shares at a weighted-average price of $996.18 (≈ $2,199,572), for aggregate proceeds of about $15,754,537. This was a sale (S) — institutional selling is common and does not necessarily reflect management sentiment.

Key Details

• Transaction date: 2026-05-06 (reported on Form 4 filed 2026-05-07) — filing appears timely.
• Shares sold: 13,620 @ $995.23 (weighted avg) and 2,208 @ $996.18 (weighted avg); total = 15,828 shares.
• Proceeds: ≈ $13,554,965 and $2,199,572, total ≈ $15,754,537.
• Price ranges (per footnotes): first block sold across $995.00–$995.9963; second across $996.00–$996.46. The reported prices are weighted averages; the filer can provide per-trade breakdown on request.
• Shares owned after transaction: not specified in the provided excerpt of the filing.

Context

• Lilly Endowment is an institutional 10% owner, not an individual executive; institutional sales can reflect portfolio rebalancing or other fund-level decisions rather than insider views of company prospects.
• No option exercises, awards, gifts, or tax-withholding codes apply here — these were straight dispositions (S).